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Introduction: Advances in technology offer various solutions that might help optimize the
care provided to patients living with chronic non-communicable diseases such as chronic
obstructive pulmonary disease (COPD). However, the efﬁcacy of tele-health in COPD is still
controversial. Despite this, there appears to be widespread adoption of this technology.
Aim: To explore the international use of tele-heath for COPD, to assess the perceptions of
clinicians employing tele-health in COPD, and to summarize the techniques that have been
used by health care providers to personalize alarm limits for patients with COPD enrolled on
tele-health programs.
Methods: A cross-sectional survey consisting of 15 questions was distributed and advertised
to health care professionals worldwide. Questions were designed to cover ﬁve different
aspects of tele-health in COPD: purpose of use, equipment type, clinician perceptions,
variables monitored, and personalization of alarm limits.
Results: A total of 138 participants completed the survey from 29 different countries. As
high as 59% of the participants had ever used tele-health for COPD, and 33% still provided
tele-health services to patients with COPD. Tele-health was most commonly used for base-
line monitoring, with 90% believing it to be effective. The three most commonly monitored
variables were oxygen saturation, heart rate, and the use of rescue medication.
Conclusion: Twenty-nine different countries use tele-health for managing COPD and there-
fore there is widespread international use of tele-health in COPD. The majority of providers
thought tele-health was effective despite evidence to the contrary.
Keywords: chronic obstructive pulmonary disease, COPD, tele-health, home monitoring,
alarm limits, perception
Introduction
The global burden of Chronic Obstructive Pulmonary Disease (COPD) is increas-
ing. According to the World Health Organisation (WHO), 251 million individuals
were living with COPD worldwide in 2016.1 A total of 3.17 million died from
COPD in 2015, making it the 4th leading cause of death worldwide.1,2 Data suggest
COPD will become the 3rd leading cause of death by 2030 if no action is taken.3
Patients diagnosed with COPD experience exacerbations which, according to the
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 report, are “an
acute worsening of respiratory symptoms that result in additional therapy”.4
Consequences of exacerbations include more rapid lung function decline, deterioration
in quality of life, death, and excess health care expenditure such that intervention to
mitigate the burden of exacerbations is important.5,6 Studies have shown that outcomes
of COPD exacerbations can be improved with different interventions.4,7–10 These
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include establishing early access to therapy as this has been
associated with faster symptom recovery and decreased risk
of hospitalization.11
Tele-health (“the remote exchange of data between a
patient at home and their clinician(s) to assist in diagnosis
and monitoring typically used to support patients with long
term conditions”).12 for COPD has the potential to improve
patient care and reduce treatment delay during exacerbations.
Studies have shown it can be used to detect exacerbations,
support education, and enhance the delivery of pulmonary
rehabilitation.13–15 However, evidence regarding its effective-
ness is controversial.16 In 2012, Mclean et al conducted a
systematic review and examined 10 randomized clinical trials
(RCTs): the use of tele-health was associated with a signiﬁcant
reduction in emergency visits and hospitalizations.17 In a retro-
spective study conducted in 2016, the rate of exacerbations
was decreased with the use of tele-health (time to next exacer-
bation ranged from 45 to 190 days, p=0.0002).18 In a more
recent review, Tomasic et al concluded that the effectiveness of
tele-health was not yet absolute, but that themajority of studies
showed a positive effect or similar outcomes to regular care.19
Sul et al also conducted a systematic review of tele-health
compared to usual care and concluded that the evidence of
beneﬁt from tele-health in COPD patients was still unclear.20
These studies and reviews underlie the latest statement from
the 2019 GOLD report which states that there is not enough
evidence to support the beneﬁt of tele-health in COPD.4
There may also be adverse events associated with tele-
health. A well-conducted RCT conducted in 2016 showed
that tele-health was associated with increased hospitalization
and home visits.21 Furthermore, the effect of tele-health
could be negative if used inappropriately, particularly with
regard to setting alarm limits for variables such as heart rate,
oxygen saturation, blood pressure, and breathlessness.22 We
recently conducted and published a survey of tele-health use
in the UK and found use to be widespread, diverse, and
associated with a signiﬁcant proportion of false alarms.23
How widespread the global use of tele-health for COPD is
not clear. We set out to study this and in particular hypothe-
sized that different health care services would be using
different methods to set tele-health alarms, with no clear
guideline on how to specify the alarm limits for each patient.
Methods
We constructed a survey consisting of 15 questions (see
Supplementary material) and advertised this to health care
professionals by circulating a weblink electronically to
international contacts (and asking them to share this
widely) and promoting the survey through Twitter,
WhatsApp, and LinkedIn. The survey was administered
via SurveyMonkeyTM between July 2017 and September
2017. The questions were developed by the authors and
tested for validity with local health care professionals. A
cover statement explained the purpose of this survey.
Under the Research Governance Framework (2005) and
Health Research Authority (HRA) review, ethics approval
was not required, as the study was a voluntary survey of
health-care professionals, with no patient involvement.
Questions were designed to cover ﬁve different aspects
of tele-health in COPD: purpose of use, equipment type,
clinician perceptions, variables monitored, and personali-
zation of alarm limits. Regarding the monitored variables,
participants were asked to select all those used by their
program. We asked about heart rate, oxygen saturation,
respiratory rate, blood pressure, temperature, peak ﬂow,
hours of CPAP use, hours of NIV use, step count, physical
activity, metabolic equivalent data, sleep quality, phlegm,
cough, breathlessness, wheeze, use of rescue medication,
and participants had the option to add any variables that
were not listed as free text. For any variables being used,
participants were then asked how the alarm limit for each
variable was set from a dropdown list (arbitrary, interna-
tional guidelines, national guidelines, personalized to the
patient, don’t know, or not applicable). Participants who
indicated that the alarm limit was personalized were asked
how this was done. Participants did not have to answer all
the questions.
With regard to questions on clinician perception,
responses were graded on a Likert scale between 1 (not
at all) and 10 (very much so). The Statistical Package for
the Social Sciences (SPSS) version 24 was used to analyze
the collected responses. p≤0.05 was accepted as the level
of signiﬁcance.
Results
A total of 138 participants completed the survey from 29
different countries, across 6 continents. The geographical
location of the respondents is shown in Figure 1. The
majority were from Saudi Arabia 30/138 (22.0%) and the
United States 29/138 (21.0%) with the rest 35/138 (25.0%)
from elsewhere. We have not included our previously
published UK data in this analysis. Of the respondents,
58/65 (42%) were respiratory therapists, 27% doctors,
15% miscellaneous, 14% physiotherapists, and 2% nurses.
Eighty-two out of 138 (59%) of practitioners had used
tele-health for COPD, and currently, 45 (33%) still
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provided tele-health services to patients diagnosed with
COPD.
Perception
In the opinion of the provider, 124/138 (90%) thought that
tele-health was useful for COPD patients with a median
(interquartile range (IQR)) score of 8 out of 10 (6–10) on
the Likert scale. In respondents who had used (n=81, med-
ian (IQR) 8 (6–9)) versus had not used (n=43, median (IQR)
8 (6–10)) tele-health, there was no signiﬁcant difference in
perception of utility (p=0.454). The providers’ perspective
of tele-health usefulness in COPD was assessed from their
written free-text comments and was based on cost-effec-
tiveness, improved quality of life, self-management, moti-
vation, early detection of exacerbation, prevention of
exacerbation, monitoring of exacerbations, prevention of
rehospitalization, and avoidance of hospital visits.
Purpose and equipment
Of the providers who still used tele-health, 43% used it for
baseline monitoring, 34% for early detection of exacerba-
tions, 31% for monitoring recovery from an exacerbation,
and 18% for other purposes (some participants used it for
more than one purpose). With regard to the equipment used
(hardware), more than half of the participants (56%) used
smartphones/tablet app, 28% a ﬁxed telephone, 16% a ﬁxed
monitoring station, 6% videophone, and 5% miscellaneous.
Figure 2 shows the variables most frequently monitored
among participants who used tele-health 73/82 (89.0%).
Variables monitored varied between 1% (CAT & MRC
score) to 86% (oxygen saturation), but only 10 variables
were reported as monitored by more than 50% of the
respondents. Six were physiological variables and four
were symptoms. Oxygen saturation, heart rate, and use of
rescue medication were the most common variables.
Alarm limits
Table 1 shows how the alarm limits were set for each
variable. Two techniques were commonly selected by the
participants: “National guidelines” or “personalized”. With
regard to the method of personalization, the participants’
answers can be classiﬁed into observations taken at time of
assessment, historical trend, age/gender, or set as a 20%
change on patient’s baseline.
With regard to sensitivity of technique to detect exacer-
bation, 92% of the participants responded and 63%
thought their alarm technique was sufﬁciently sensitive
to identify exacerbations. Eighty-two out of 82 participants
believed that personalized rather than arbitrary alarm lim-
its made their service more efﬁcient, with a median (IQR)
score of 7 (6–8) on the Likert scale.
Figure 3 shows the perceived proportion of false
alarms generated by tele-health systems in the opinion of
81/138 (59%) participants. The majority believed that 20–
60% of the alarms were false.
Discussion
We have conducted an international survey to explore the
use of tele-health in COPD and to summarize the techni-
ques used by health care providers to personalize alarm
limits for COPD patients enrolled in tele-health programs
globally. Our key ﬁndings are of the 138 responders, 45
(33%) currently use tele-health, 90% of the practitioners
thought tele-health was useful in COPD, tele-health is
most commonly delivered from a smartphones/tablet app,
and the most common variables monitored are oxygen
saturation, heart rate, and use of rescue medication. The
majority of practitioners set alarm limits for these vari-
ables based on national guidelines – though we know of no
such guidance. For alarm limit personalization, different
methods were reported but with no evidence base, parti-
cularly for physiological variables.
Even though the efﬁcacy of tele-health in COPD is still
in question, the majority of providers believed that tele-
health was beneﬁcial for COPD patients, despite the lack
of robust evidence, and despite a diverse range of methods
and alarm techniques being used. These ﬁndings suggest
the need for further studies to evaluate why providers’
perceptions do not match the current evidence, and the
22%
21%
17%
6%
5%
4%
25%
Geographical location of the participants
Saudi Arabia
United States
China
Jordan
Russia
Canada
Other
Figure 1 The geographical location of the respondents expressed in percentage.
Other includes Serbia, Australia, Switzerland, Austria, Italy, Germany, Netherlands,
Norway, Denmark, Slovenia, Malta, Ghana, Guyana, Namibia, Pakistan, Philippines,
Niger, Singapore, South Africa, Sir Lanka, and Mongolia.
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need for greater awareness among providers about tele-
health in COPD and how objectively to assess potential
beneﬁts and harms. Ayatollahi et al reported that the lack
of knowledge found in health care providers could inﬂu-
ence their perception of beneﬁt.24
The provision of tele-health services can be achieved
through several applications. Based on our ﬁndings, smart-
phones/tablet hardware were the most commonly used.
The potential for better monitoring of COPD patients via
smartphones is plausible. Ding et al reported that using a
smartphone application contributed to a decrease in the
number of hospital admissions and emergency department
attendances as this could help distinguish changes in
symptoms prior to an exacerbation.25 A recent meta-ana-
lysis noted that patients monitored via smartphones tended
to have fewer COPD exacerbations compared to conven-
tional care.26 Further, Williams et al demonstrated the
positive impact of using smartphone apps in increasing
the level of self-management and awareness of COPD
patients.27
Heart rate, oxygen saturation, and use of rescue med-
ication were the most common variables being monitored.
In the pilot study conducted by Hurst et al in 2010, we
were able to detect a signiﬁcant change in heart rate and
oxygen saturation before exacerbation onset.28 The max-
imum change in heart rate was an increase of 3.09SD and
the maximum decrease in oxygen saturation was −1.24SD
at day 2 of exacerbation. Moreover, in a previous systema-
tic review in 2016, we summarized the potential of mon-
itoring physiological variables for detection of
exacerbations.29 Whilst demonstrating proof-of-concept,
we conclude that there remains the need for more clinical
trials assessing the potential for monitoring physiological
variables to provide early detection of COPD
exacerbations and to reliably distinguish this from day-
to-day symptom variation.
Another key factor that may improve the efﬁcacy of
tele-health service is the setting of alarm limits. Our ﬁnd-
ings showed that the majority of providers (89%) thought
personalizing the alarm limits for each patient improved
the care provided, and 63% thought their technique was
sufﬁciently sensitive to detect exacerbations, at the
expense of a high proportion of false alarms. The latter
could lead to alarm fatigue.30 which therefore may affect
service quality, patient trust, and cost-effectiveness.
Studies have shown that alarm limits are often breached
because of technical malfunctions, sensor malpositioning,
or changes in therapy rather than clinical deteriorations.31
Well-conducted trials will be needed to establish standar-
dized guidelines for personalizing alarm limits for COPD
patients enrolled in a tele-health service as the reported
personalization methods from providers are not evidence
based, even though they were similar to those previously
reported in our systematic review. A novel approach to
detecting alarm limits in tele-health would be machine
learning, which has the potential to increase the efﬁciency
and cost-effectiveness of tele-health. However, none of our
participants reported the use of machine learning, even
though it has been used in some clinical trials with
COPD patients and showed promising results in terms of
sensitivity and speciﬁcity.19
According to our ﬁndings, there is widespread interna-
tional use of tele-health in COPD. In a prior survey con-
ducted by our department restricted to health care
providers in England and Wales.23 We found similar mis-
match between providers’ perceptions of tele-health use-
fulness compared to current evidence, and a high rate of
false alarms. There were however some differences in
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Temperature
Respiratory rate
Physical activity
Cough
Blood pressure
Wheeze symptoms
Breathlessness symptoms
Use of rescue medication
Heart rate
Oxygen saturation
Percentage %
V
ar
ia
bl
es
Variables monitored 
Figure 2 Variables being monitored by tele-health providers.
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global use compared to England and Wales. Globally
smartphone/tablet apps were the most used frequent hard-
ware use, whereas in England and Wales, a ﬁxed monitor-
ing station was the most common method. This draws
attention to the variability between the two methods and
the impact of this difference in evaluating the cost-effec-
tiveness of tele-health in COPD. Findings from this inter-
national survey showed that alarm limits were most
frequently set based on guidelines or from known ‘normal’
limits (for example, heart rate 60–100 beats min−1).
Strengths and limitations
Our survey has some limitations. The responsibility for
delivering tele-health services for COPD worldwide is not
clear; thus, we cannot be sure if the survey reached a
representative sample of appropriate providers. Although
Table 1 The participant’s percentage of how alarm limit was set for each variable
Variables Arbitrary/what
feels right
Local
guideline
National
guideline
Personalized (based on data
from that patient)
Don’t
know
Not
applicable
Total
Heart rate 6%
3
2%
1
53%
25
34%
16
4%
2
0%
0
47
Oxygen
saturation
7%
3
2%
1
57%
26
28%
13
4%
2
2%
1
46
Use of
medication
7%
3
5%
2
52%
23
32%
14
2%
1
2%
1
44
Respiratory
rate
5%
2
5%
2
61%
26
21%
9
5%
2
5%
2
43
Breathlessness 12%
5
3%
1
49%
20
29%
12
2%
1
5%
2
41
Blood
pressure
8%
3
10%
4
63%
25
15%
6
5%
2
0%
0
40
Cough
symptoms
10%
4
8%
3
33%
13
43%
17
3%
1
5%
2
40
Wheeze 3%
1
3%
1
47%
18
40%
15
3%
1
5%
2
38
Physical
activity
5%
2
5%
2
43%
16
32%
12
5%
2
8%
3
37
Hours of NIV
use
6%
2
6%
2
39%
14
31%
11
6%
2
14%
5
36
Temperature 6%
2
8%
3
70%
25
11%
4
3%
1
3%
1
36
Phlegm
symptoms
6%
2
6%
2
29%
10
44%
15
6%
2
9%
3
34
Peak ﬂow 9%
3
3%
1
38%
13
27%
9
3%
1
21%
7
34
Hours of
CPAP use
3%
1
9%
3
44%
14
22%
7
6%
2
16%
5
32
Step count 3%
3
6%
3
41%
3
25%
3
3%
3
21%
3
32
Sleep quality 3%
1
7%
2
36%
11
36%
11
7%
2
13%
4
31
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we had wide geographical spread, respondents were con-
centrated in Saudi Arabia and the United States. The
strength of our survey is that, to our knowledge, no pre-
vious survey investigating the techniques used for perso-
nalization alarm limits, nor the purpose of the use of tele-
health with COPD, have been conducted worldwide. It is
not clear if prior positive or negative use might bias
providers to wish to take part.
Conclusion
Twenty-nine different countries use tele-health for managing
COPD and therefore there is widespread international use of
tele-health in COPD. The majority of providers thought tele-
health was effective despite evidence to the contrary.
Different types of hardware and different non-standardized
techniques to personalize alarm limits are used.
Data availability
We will consider requests for data sharing via e-mail to the
corresponding author.
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